Jesús Gómez‐Mateos

1.9k total citations
42 papers, 1.4k citations indexed

About

Jesús Gómez‐Mateos is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Jesús Gómez‐Mateos has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 19 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in Jesús Gómez‐Mateos's work include Hepatitis C virus research (18 papers), Liver Disease Diagnosis and Treatment (17 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Jesús Gómez‐Mateos is often cited by papers focused on Hepatitis C virus research (18 papers), Liver Disease Diagnosis and Treatment (17 papers) and Pneumocystis jirovecii pneumonia detection and treatment (8 papers). Jesús Gómez‐Mateos collaborates with scholars based in Spain, France and United States. Jesús Gómez‐Mateos's co-authors include Juan A. Pineda, Juan Macı́as, Fernando Lozano, Luís F. López‐Cortés, José Ángel García-García, Antonio Rivero, Nicolás Merchante, Mercedes Cruz-Ruiz, José Antonio López Mira and Ángela Camacho and has published in prestigious journals such as PLoS ONE, Hepatology and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Jesús Gómez‐Mateos

42 papers receiving 1.3k citations

Peers

Countries citing papers authored by Jesús Gómez‐Mateos

Since Specialization

Citations

This map shows the geographic impact of Jesús Gómez‐Mateos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jesús Gómez‐Mateos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jesús Gómez‐Mateos more than expected).

Fields of papers citing papers by Jesús Gómez‐Mateos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jesús Gómez‐Mateos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jesús Gómez‐Mateos. The network helps show where Jesús Gómez‐Mateos may publish in the future.

Co-authorship network of co-authors of Jesús Gómez‐Mateos

This figure shows the co-authorship network connecting the top 25 collaborators of Jesús Gómez‐Mateos. A scholar is included among the top collaborators of Jesús Gómez‐Mateos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jesús Gómez‐Mateos. Jesús Gómez‐Mateos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Incidence of recently acquired hepatitis C virus infection among HIV‐infected patients in southern Spain 2020 ·HIV Medicine ·Alejandro González‐Serna, Juan Macı́as, Rosario Palacios, Cristina Gómez‐Ayerbe, Francisco Téllez, Antonio Rivero‐Juárez, (unknown), Jesús Santos, Luís Miguel Real, (unknown), Jesús Gómez‐Mateos, Juan A. Pineda, (unknown)	10
2	The PNPLA3 Genetic Variant rs738409 Influences the Progression to Cirrhosis in HIV/Hepatitis C Virus Coinfected Patients 2016 ·PLoS ONE ·Rocío Núñez‐Torres, Juan Macı́as, M.J. Mancebo, Mario Frías, Giovanni Dolci, Francisco Téllez, Dolores Merino, Nicolás Merchante, Jesús Gómez‐Mateos, Giovanni Guaraldi, Antonio Rivero‐Juárez, Juan A. Pineda, Luís Miguel Real, (unknown)	14
3	Core amino acid variation at position 110 is associated with sustained virological response in Caucasian patients with chronic hepatitis C virus 1b infection 2014 ·Archives of Virology ·Federico A. Di Lello, (unknown), Karin Neukam, (unknown), Javier R. Guelfo, Celia Cifuentes, Juan Macı́as, José-Carlos Palomares-Salas, Jesús Gómez‐Mateos, Juan A. Pineda, Luís Miguel Real	3
4	Sustained virological response to pegylated interferon plus ribavirin leads to normalization of liver stiffness in hepatitis C virus-infected patients 2013 ·Enfermedades Infecciosas y Microbiología Clínica ·Juan Macı́as, Antonio Rivero, Celia Cifuentes, Ángela Camacho, Karin Neukam, Antonio Rivero‐Juárez, José Antonio López Mira, José Miguel Cisneros, Jesús Gómez‐Mateos, Juan A. Pineda	8
5	Liver stiffness predicts clinical outcome in human immunodeficiency virus/hepatitis C virus-coinfected patients with compensated liver cirrhosis 2012 ·Hepatology ·Nicolás Merchante, Antonio Rivero‐Juárez, Francisco Téllez, Dolores Merino, Maria José Ríos-Villegas, Manuel Márquez, Mohamed Omar, Juan Macı́as, Ángela Camacho, (unknown), Jesús Gómez‐Mateos, Antonio Rivero, Juan A. Pineda	61
6	Prediction of response to pegylated interferon plus ribavirin in HIV/hepatitis C virus (HCV)-coinfected patients using HCV genotype, IL28B variations, and HCV-RNA load 2011 ·Journal of Hepatology ·Karin Neukam, Ángela Camacho, Antonio Carúz, Norma Rallón, Almudena Torres-Cornejo, Jürgen K. Rockstroh, Juan Macı́as, Antonio Rivero, José M. Benito, Luís F. López‐Cortés, Jacob Nattermann, Jesús Gómez‐Mateos, Vincent Soriano, Juan A. Pineda	35
7	Influence of concomitant antiretroviral therapy on the rate of sustained virological response to pegylated interferon plus ribavirin in hepatitis C virus/HIV-coinfected patients 2007 ·Journal of Antimicrobial Chemotherapy ·Juan A. Pineda, (unknown), Ignacio de los Santos, (unknown), A. Rivero, (unknown), J.A. Girón González, Maria José Ríos-Villegas, Mercedes González‐Serrano, Antonio Collado, José Ángel García-García, (unknown), Luís F. López‐Cortés, Jesús Gómez‐Mateos	43
8	Clinical progression of hepatitis C virus–related chronic liver disease in human immunodeficiency virus–infected patients undergoing highly active antiretroviral therapy 2007 ·Hepatology ·Juan A. Pineda, José Ángel García-García, Manuela Aguilar‐Guisado, Maria José Ríos-Villegas, Josefa Ruiz‐Morales, Antonio Rivero, José del Valle, Rafael J. Luque, Jesús Rodríguez‐Baño, Mercedes González‐Serrano, Ángela Camacho, Juan Macı́as, Israel Grilo Bensusán, Jesús Gómez‐Mateos	148
9	Low-level liver enzyme elevations during HAART are not associated with liver fibrosis progression among HIV/HCV-coinfected patients 2006 ·Journal of Antimicrobial Chemotherapy ·(unknown), Juan Macı́as, (unknown), José Ángel García-García, Nicolás Merchante, José del Valle, Laila Abdel‐Kader Martín, Fernando Lozano, Jesús Gómez‐Mateos, Juan A. Pineda	4
10	Insulin resistance is not associated with liver fibrosis progression in HIV/hepatitis C virus‐coinfected patients 2006 ·Journal of Viral Hepatitis ·Nicolás Merchante, Juan Macı́as, (unknown), (unknown), José Ángel García-García, J Mira, Juan E. Corzo, Jesús Gómez‐Mateos, Fernando Lozano, Juan A. Pineda	18
11	Relationship between Osteopenia, Free Testosterone, and Vitamin D Metabolite Levels in HIV-Infected Patients with and without Highly Active Antiretroviral Therapy 2005 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), Juan Macı́as, Mercedes Cruz-Ruiz, (unknown), (unknown), José Ángel García-García, Jesús Gómez‐Mateos, Fernando Lozano, Juan A. Pineda	25
12	Increased Hepatocyte Fas Expression and Apoptosis in HIV and Hepatitis C Virus Coinfection 2005 ·The Journal of Infectious Diseases ·Juan Macı́as, Miguel Á. Japón, Carmen Sáez, (unknown), José Antonio López Mira, José Ángel García-García, Nicolás Merchante, (unknown), Fernando Lozano, Jesús Gómez‐Mateos, Juan A. Pineda	33
13	Effect of antiretroviral drugs on liver fibrosis in HIV-infected patients with chronic hepatitis C 2004 ·AIDS ·Juan Macı́as, V. Castellano, Nicolás Merchante, (unknown), José Antonio López Mira, Carmen Sáez, José Ángel García-García, Fernando Lozano, Jesús Gómez‐Mateos, Juan A. Pineda	128
14	Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment 2002 ·Scandinavian Journal of Rheumatology ·L. Mayordomo, José Luis Marenco, Jesús Gómez‐Mateos, E Rejón	52
15	Community-Acquired Bacterial Pneumonia in Human Immunodeficiency Virus–Infected Patients 2000 ·American Journal of Respiratory and Critical Care Medicine ·Elisa Cordero, Jerónimo Pachón, Antonio Rivero, J Giron, Jesús Gómez‐Mateos, (unknown), M. Torres-Tortosa, Mercedes González‐Serrano, Luis Aliaga, Antonio Collado, José Hernández‐Quero, (unknown), Enrique Nuño	47
16	Haemophilus influenzae Pneumonia in Human Immunodeficiency Virus-Infected Patients 2000 ·Clinical Infectious Diseases ·Elisa Cordero, Jerónimo Pachón, Antonio Rivero, J Giron, Jesús Gómez‐Mateos, (unknown), M. Torres-Tortosa, Mercedes González‐Serrano, (unknown), Antonio Collado, José Hernández‐Quero, (unknown), Enrique Nuño, (unknown)	30
17	Fulminant Septic Shock in AIDS Patients Caused by Disseminated Cryptococcosis 1999 ·European Journal of Clinical Microbiology & Infectious Diseases ·Fernando Lozano, Jesús Gómez‐Mateos, José Antonio Irles Rocamora, Bárbara Meléndez, (unknown)	2
18	Interleukin 6 in Cerebrospinal Fluid of Patients with Meningitis is not a Useful Diagnostic Marker in the Differential Diagnosis of Meningitis 1997 ·Annals of Clinical Biochemistry International Journal of Laboratory Medicine ·Luís F. López‐Cortés, Mercedes Cruz-Ruiz, Jesús Gómez‐Mateos, (unknown), (unknown), Jiménez-Mejías Me	23
19	Adenosine Deaminase Activity in the CSF of Patients with Aseptic Meningitis: Utility in the Diagnosis of Tuberculous Meningitis or Neurobrucellosis 1995 ·Clinical Infectious Diseases ·Luís F. López‐Cortés, Mercedes Cruz-Ruiz, Jesús Gómez‐Mateos, (unknown), (unknown), Jerónimo Pachón, Juan González del Castillo	51
20	Measurement of Levels of Tumor Necrosis Factor- and Interleukin-1 in the CSF of Patients with Meningitis of Different Etiologies: Utility in the Differential Diagnosis 1993 ·Clinical Infectious Diseases ·Luís F. López‐Cortés, Mercedes Cruz-Ruiz, Jesús Gómez‐Mateos, (unknown), Jaime Palomino, (unknown)	67

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact